Osteoporosis treatment and 10 years' oestrogen receptor+ breast cancer outcome in postmenopausal women treated with aromatase inhibitors

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Claudia Allemani, Hannah K. Weir, Helena Carreira et al. · The Lancet · 2014 · 2.7K citations · Full text

Medicine, Biostatistics, Oncology +17

Bisphosphonates induce apoptosis in human breast cancer cell lines

S G Senaratne, Grisha Pirianov, Janine Mansi et al. · British Journal of Cancer · 2000 · 424 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

Pamela J. Goodwin, Marguerite Ennis, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 2009 · 336 citations

Medicine, Nutritional Sciences, Oncology +17

Antitumor Effects of Clinical Dosing Regimens of Bisphosphonates in Experimental Breast Cancer Bone Metastasis

Florence Daubiné, Céline Le Gall, Jürg A. Gasser et al. · JNCI Journal of the National Cancer Institute · 2007 · 225 citations · Full text

Medicine, Oncology, Pharmacology +17

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment <i>In Vivo</i>

Penelope D. Ottewell, Ning Wang, Hannah K. Brown et al. · Clinical Cancer Research · 2014 · 158 citations · Full text

Medicine, Oncology, Pharmacology +17